SEC Form 4 · accession 0000899243-16-036405
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sachiko Kuno
10% Owner
Period of report
Dec 19, 2016
Accepted (ET)
Dec 29, 2016 · 5:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dec 19, 2016 | G | 1,000,000 | $0.00 | D | 0 | I | By Revocable Trust |
| Class A Common Stock | holding | — | — | — | 8,137,344 | I | By SK Impact Fund, LLC |
Table II — derivative securities
No Table II lines on this filing.